2017 was an extremely busy year for our client Volition RX, the multi-national company developing a simple, cost effective blood test to diagnose a range of cancers. They continued the drive to get their product approved and on the market starting the year with the opening of a new state of the art 20,000 square foot laboratory at their facility in Namur. Volition America was formed shortly followed by the start of a large colorectal cancer screening trial in collaboration with the Early Detection Research Network part of the prestigious U.S. National Cancer Institute. In Asia a Memorandum of Understanding was signed with the National Taiwan University to conduct two large colorectal clinical trials.
As we continue to document their journey to market, these are just some of the highlights featured in the 2017 overview film we recently created for them; collating footage from across the year with interviews from many of the team. To watch the film and hear about the continued development and growth of the company and learn about another exciting year ahead with some key clinical milestones coming up in 2018 click here.